AtaiBeckley (ATAI) Total Current Liabilities (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Total Current Liabilities of $25.0 million for Q1 2026, up 6.32% quarter-over-quarter from $23.5 million in Q4 2025.
AtaiBeckley (ATAI) Total Current Liabilities (2020 - 2026) Analysis & Trends
AtaiBeckley's Total Current Liabilities history runs 3 years deep, the most recent figure standing at $25.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities changed N/A year-over-year to $25.0 million; the TTM figure through Mar 2026 stood at $25.0 million (changed N/A YoY), while the FY2025 annual figure was $23.5 million, down 5.9% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $25.0 million, up from $23.5 million in the prior quarter.
- The five-year high for Total Current Liabilities was $25.0 million in Q1 2026, with the low at $23.5 million in Q4 2025.
- A 5-year average of $20.3 million and a median of $19.9 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities declined 24.76% in 2024, then jumped 89.84% in 2025.
- AtaiBeckley's Total Current Liabilities stood at $25.0 million in 2024, then dropped by 5.9% to $23.5 million in 2025, then rose by 6.32% to $25.0 million in 2026.
- Business Quant data shows ATAI's Total Current Liabilities at $25.0 million in Q1 2026, $23.5 million in Q4 2025, and $25.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | 16.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.53 Mn |
| Mar 31, 2026 | 24.96 Mn |
| Dec 31, 2025 | 23.48 Mn |
| Sep 30, 2025 | 16.54 Mn |
| Jun 30, 2025 | 25.55 Mn |
| Mar 31, 2025 | 28.50 Mn |
| Dec 31, 2024 | 24.95 Mn |
| Dec 31, 2024 | 24.95 Mn |
| Sep 30, 2024 | 19.64 Mn |
| Jun 30, 2024 | 17.64 Mn |
| Mar 31, 2024 | 15.01 Mn |
| Dec 31, 2023 | 20.12 Mn |
| Sep 30, 2023 | 19.70 Mn |
| Jun 30, 2023 | 17.93 Mn |
| Mar 31, 2023 | 19.95 Mn |
| Dec 31, 2022 | 19.90 Mn |
| Sep 30, 2022 | 25.91 Mn |
| Jun 30, 2022 | 21.96 Mn |
| Mar 31, 2022 | 22.09 Mn |
| Dec 31, 2021 | 20.94 Mn |